SCRI - Florida Cancer Specialists - South Region Research Office — Fort Myers, Florida

SCRI - Florida Cancer Specialists - South Region Research Office is a clinical research site located in Fort Myers, Florida, United States 33901.

Crixeo Health Trust Score: 64/100 (FAIR). This profile has not yet been claimed by the site owner.

SCRI - Florida Cancer Specialists - South Region Research Office has participated in 3 clinical trials with 3 currently active.

Therapeutic areas: Advanced Upper Gastrointestinal Tract Adenocarcinoma, Platinum-resistant Ovarian Cancer, Advanced Non-Small Cell Lung Cancer.

Sponsors: Arcus Biosciences, Inc., Genmab, Mirati Therapeutics Inc..

Sponsor Feasibility Report

Trust Score: 64/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for SCRI - Florida Cancer Specialists - South Region Research Office?

SCRI - Florida Cancer Specialists - South Region Research Office has a Crixeo Trust Score of 64/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has SCRI - Florida Cancer Specialists - South Region Research Office conducted?

SCRI - Florida Cancer Specialists - South Region Research Office has 3 clinical trials on record, with 3 currently active. Their work covers Advanced Upper Gastrointestinal Tract Adenocarcinoma, Platinum-resistant Ovarian Cancer, Advanced Non-Small Cell Lung Cancer.

Is SCRI - Florida Cancer Specialists - South Region Research Office accredited by Crixeo Health?

SCRI - Florida Cancer Specialists - South Region Research Office has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about SCRI - Florida Cancer Specialists - South Region Research Office?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.